What is LOPJLB’s current signal on PEPG?

LOPJLB’s latest quantitative signal on PepGen Inc. (PEPG) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is PEPG in?

PepGen Inc. (PEPG) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does PepGen Inc. (PEPG) do?

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the trea…

Where is PepGen Inc. based / listed?

PepGen Inc. is based in US, listed on NASDAQ.

PepGen Inc. (PEPG)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.38-0.83%Close

SELLCRISIS · day 12

[SCORES & PROFILE]

FUND: 13
VALUE: 9
GROWTH: 45
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-30.6%

REV YoY-

ROE-51.0%

EPS YoY-

ROA-50.9%

GROSS

NET

[VALUATION]

P/E TTM-1.54

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B1.34

P/FCF-

EV/EBITDA-2.26

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E13.46

ALTMAN Z-

CURR RATIO13.36

ND/EBITDA-

BETA1.97

PepGen Inc. (PEPG)

Key stats

Prediction markets

FUNDAMENTALS

Company news